Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models.
Pancreatic cancer is an aggressive malignancy with morbidity rates almost equal to mortality rates because of the current lack of effective treatment options. Here, we describe a targeted approach to treating pancreatic cancer with effective therapeutic efficacy and safety in noninvasive imaging models. We developed a versatile expression vector "VISA" (VP16-GAL4-WPRE integrated systemic amplifier) and a CCKAR (cholecystokinin type A receptor) gene-based, pancreatic-cancer-specific promoter VISA (CCKAR-VISA) composite to target transgene expression in pancreatic tumors in vivo. Targeted expression of BikDD, a potent proapoptotic gene driven by CCKAR-VISA, exhibited significant antitumor effects on pancreatic cancer and prolonged survival in multiple xenograft and syngeneic orthotopic mouse models of pancreatic tumors with virtually no toxicity.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
DOI
ISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Transgenes
- Receptors, Cholecystokinin
- Pancreatic Neoplasms
- Oncology & Carcinogenesis
- Models, Biological
- Mice, Inbred C57BL
- Mice
- Animals
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
Citation
Published In
DOI
ISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Transgenes
- Receptors, Cholecystokinin
- Pancreatic Neoplasms
- Oncology & Carcinogenesis
- Models, Biological
- Mice, Inbred C57BL
- Mice
- Animals
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology